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As podiatric surgery has continued to evolve and advance in complexity, so has the understanding of the factors affecting healing, not only of the soft tissue, but also of the bone. Many surgeons have studied orthobiologic approaches as a method to supplement their surgical necessities. Recently, the use of bone marrow aspirates (BMAs) containing mesenchymal stromal cells (MSCs) has become increasingly popular in foot and ankle surgery (1) (2) (3) . In the continually evolving field, BMAs have arisen as a well-documented method to locally introduce endogenous growth factors such as platelet derived growth factor and transforming growth factor-b into an area to initiate healing of fusion sites, fresh fractures, and areas of devascularization (4, 5) . They have also been used to enhance healing at graft sites (6, 7) . BMAs have been shown to have greater levels of both endogenous bone morphogenetic protein 2 and vascular endothelial growth factor-a, thus providing superior quality compared with the harvest of peripheral blood (8) .
Most orthobiologic materials, compared with the current reference standard of autologous bone grafting, contain not only osteoconductive (scaffold) and osteoinductive (signal protein) properties but also osteogenic qualities (MSCs) (1) . The osteogenic qualities of BMAs (MSCs) have been well documented and used to supplement orthobiologic substances containing only osteoinductive and/or osteoconductive properties (9) (10) (11) . Moreover, MSCs secrete a multitude of cytokines and growth factors, affecting the surrounding cells and matrix to regulate tissue regeneration (12) . Several studies have reported the successful aspiration of BMAs at sites with a high concentration of red bone marrow, such as the vertebral body, iliac crest, and proximal tibia (13) . Reproducible concentrations of human MSCs (hMSCs) were also obtained from both the proximal humerus and the distal femur during arthroscopy (14, 15) . However, many podiatric surgeons are limited in their ability to harvest aspirates from these sites because of such factors as state laws, hospital restrictions, or other inhibitory factors. Although many podiatric surgeons might choose to harvest autografts from the calcaneus or even the tibia, this is not a benign procedure and can be associated with surgical morbidity (16) . The replacement of red bone marrow by yellow bone marrow during the normal aging process further diminishes the options for the podiatric surgeons (17) .
In the present study, we attempted to identify the presence or absence of multipotent MSCs in the calcaneal body using a currently accepted method of sampling. Using the guidelines from the International Society for Cellular Therapy (ISCT) (18) , the minimum criteria for documenting the presence of hMSCs must include the following:
1. Plastic adherence when maintained in standard culture conditions 2. The presence or enhanced expression (þ) of cell surface markers such as CD105, CD73, and CD90 and the absence or suppressed expression (À) of CD45, CD34, CD14 or CD11 b, CD79 or CD19, and human leukocyte antigen class II 3. The ability to differentiate into osteoblasts, adipocytes, and chondrocytes in vitro
To our knowledge, no such study has been previously published. Our hypothesis was that the calcaneus contains a viable population of multipotent MSCs capable of differentiating into osteoblasts, chondrocytes, and adipocytes. Because the present study was an evaluation of the presence of MSCs, patients were excluded for a variety of reasons in an attempt to sample a "healthy" patient population.
Patients and Methods

Study Population
The study was conducted under approved protocol no. 10-51 at Memorial Hospital of Rhode Island. Ten patients were selected for the present prospective, case-controlled study. Patients were excluded in an attempt to sample a healthy patient population. The criteria for selection included several factors, such as age, surgical and disease history, and smoking and substance abuse. The patients selected were aged 18 to 65 years. All surgeries were elective in nature, and no history of recent trauma to the lower extremity was present in any of the patients. Patients with a history of systemic disease such as diabetes mellitus, rheumatoid arthritis, chronic obstructive pulmonary disease, chronic kidney disease, end-stage renal disease, and cardiovascular disease were all excluded from the present study. Patients with a documented presence of peripheral artery disease and/or peripheral neuropathy were also excluded from the present study. Patients were also required to have quit smoking for !1 year to be eligible for the study. Chronic use of corticosteroids or other immunosuppressant therapy was also a criterion for exclusion from the study. Smoking, alcohol abuse, and substance abuse were also disqualifying factors from participation in the study.
Surgical Technique
The patients were placed in a supine position. An ipsilateral bump was placed under the hip to ensure adequate exposure of the lateral wall of the calcaneus. After carefully identifying and avoiding the sural nerve and peroneal tendons, 52 mL of BMA was collected with 8 mL of heparin using an 8-gauge Jamshidi Ô needle (BD Biosciences, Franklin Lakes, NJ) inserted percutaneously through the lateral wall of the calcaneal body with continuous retrograde force. The skin wound was then closed with a single 4-0 nylon simple suture. The patients were followed up for 10 months.
Isolation of hMSCs
hMSCs were isolated by Percoll density centrifugation, followed by plastic adherence, as previously described (19, 20) . The entire aspirate volume was mixed 1:1 with phosphate-buffered saline (PBS). The diluted bone marrow was subsequently layered over a Ficoll-Paque density gradient medium (1.073 g/mL) and centrifuged at 400g for 30 minutes to isolate the human mononuclear cells (hMNCs). The mononuclear cells were then washed twice with PBS and resuspended in hMSC growth medium. The growth medium consisted of minimum essential medium-a as basal medium, supplemented with 10% fetal bovine serum, antibiotics-antimycotics (100 U/mL penicillin, 100 mg/mL streptomycin, 0.25 mg/mL fungizone), and 0.1 mM nonessential amino acids (Thermo Fisher Scientific, Waltham, MA). The cells were counted using a hemocytometer and the trypan blue exclusion method and finally seeded at a density of 10 Â 10 3 cells/ cm 2 on tissue culture-treated plastic (TCP). The cells were kept in an incubator at 37 C, 5% CO 2 , and 95% humidity for !24 hours before testing plastic adherence by observation of the culture specimens under a microscope. The observation of adherent cells deemed the specimen positive for the first minimal criterion of MSCs.
Flow Cytometry
The cells seeded on TCP were washed with PBS to remove any nonadherent cells present in the cell culture. The adherent cells were then detached from the TCP using 0.25% trypsin-ethylenediaminetetraacetic acid. The cells were resuspended in Pharmingen Stain Buffer (BD Biosciences, Franklin Lakes, NJ) and subsequently stained with the respective fluorescently conjugated antibody. Flow cytometric analysis was performed on a FACSCalibur (BD Biosciences, Franklin Lakes, NJ), and a minimum of 20,000 events was recorded for each sample. The analysis was performed using FlowJo (Tree Star, Inc, Ashland, OR) on dot plots to obtain a more accurate quantification compared with histogram analysis. Each specimen was tested for the presence of both positive (CD105 [SH2/Endoglin], CD73 [SH3/5 0 nucleotidase], and CD90 [thymocyte differentiation antigen 1, (Thy-1)]) and negative (CD34, CD45) hMSC markers.
Differentiation Assays
The potential of isolated cells to differentiate into mesenchymal lineages was evaluated using the StemPro Osteogenesis Differentiation Kit, StemPro Chondrogenesis Differentiation Kit, and StemPro Adipogenesis Differentiation Kit (Thermo Fisher Scientific, Waltham, MA), according to the manufacturer's instructions. Control cultures were run in parallel during all differentiation assays, with cells cultured in growth media without supplemental differentiation factors.
For osteogenic differentiation, the cells were seeded into 12-well plates at a density of 5 Â 10 3 cells/cm 2 and incubated in growth medium for 4 days until the cells reached confluency. The cells were then maintained in osteogenic medium for 21 days, with the medium refreshed every 2 to 3 days. Cells that underwent osteogenesis were fixed with 4% formaldehyde and stained with 2% Alizarin red S solution (pH 4.2) for the detection of calcium accumulation. Chondrogenic differentiation was induced in micromass culture. Micromass cultures were generated by seeding 5-mL droplets of cell suspension (1.6 Â 10 7 cells/mL) in the center of 12-well plate wells. The cells were then cultivated under high humidity conditions for 2 hours, and warm chondrogenic medium was added to cells. After 14 days of culture, the cells were fixed with 4% formaldehyde and stained with 1% Alcian blue for the detection of glycosaminoglycan in cartilage. For adipogenic differentiation, the cells were seeded into 12-well plates at a density of 10 Â 10 4 cells/cm 2 and cultivated in growth medium until the cells reached confluency. The medium was then replaced with adipogenic medium and the cultures continued for 14 days. Cells that underwent adipogenesis were fixed with 4% formaldehyde and stained with Oil Red O to visualize lipid droplet formation.
Results
BMAs were harvested from the calcaneus of the 10 patients enrolled in the study. All patients were followed up for an average of 4 (range 2 to 10) months. The suture was removed at approximately 2 weeks after bone marrow aspiration. All 10 patients remained non- Fig. 1 . Stem cell morphology at day 16 (specimen no. 110211A). Cells attached to plastic and grew into a confluent cell layer. weightbearing for !6 (average 12) weeks. A return to weightbearing status was determined by the healing factors in the primary procedure performed and was not influenced by the bone marrow aspiration. No evidence of any postoperative complications related to the harvest were noted, including, but not limited to, sural nerve injury, peroneal tendon injury, and calcaneal fracture. The described technique for harvesting BMAs from the human calcaneus in the present study is safe, as previously demonstrated in other studies (21) (22) (23) .
We next sought to identify the presence of hMSCs in BMAs from the human calcaneus. We followed the guidelines set by the ISCT (18) to document the presence of hMSCs. To isolate hMSCs from the calcaneus BMAs, hMNCs were first isolated from the BMAs using density gradient centrifugation. The collected fraction containing hMNCs was then subjected to plastic adherence, and the attached cells grew into a confluent cell layer. All 10 specimens were observed to adhere to plastic under standard culture conditions. Fig. 1 shows the plastic adherence of a representative specimen (specimen 110211a) at 16 days in culture. Using this standard, the requirement of plastic adherence was met, with all 10 specimens reported as positive.
Flow cytometric analysis was performed to study the expression of MSC surface markers. A subpopulation in the scatter plot was selected from the total population that was >90% CD105 positive in all populations to exclude the dominant hematopoietic cell population and also reduce the variability between specimens (Fig. 2) . This population was analyzed, and the percentages of cells were quantified using both the hMSC positive (CD73, CD90, CD105) and hMSC negative (CD34 and CD45) markers (Table) . The exclusion marker CD34 was noted to be low in general and the expression of CD45 substantially decreased over time. The inclusion markers CD73 and CD90, although initially only measured at about 10% of the short-term cultures, were all present in 100% of the cells in the long-term cultures. The positive marker CD105 was noted to be approximately 90% in all specimens, which was expected because the subset was based on CD105-positive cells.
Finally, the potential of isolated hMSCs to differentiate into cells of mesenchymal lineages was evaluated. hMSCs isolated from all specimens had the ability to proliferate extensively and were capable of differentiating into osteoblasts, chondrocytes, and adipocytes with the respective differentiation cues. Osteogenic differentiation was indicated by Alizarin red staining of calcium deposition at day 21 (Fig. 3A,D) . Chondrogenic differentiation was indicated by Alcian blue staining of the sulfated proteoglycans deposits at day 14 ( Fig. 3B,E) . Oil Red O staining at day 14 indicated the accumulation of lipid droplets during adipogenic differentiation (Fig. 3C,F) . The multilineage differentiation potential varied among the 10 patients.
Discussion
The purpose of the present study was to identify the presence of multipotent hMSCs in BMAs harvested from the human calcaneus. In the continually evolving field of orthobiologics, the use of autologous BMA on its own or coupled with a carrier is emerging as a viable alternative to the use of autologous bone grafting in the treatment of a variety of lower extremity pathologic entities (24) . A variety of factors currently limit podiatric foot and ankle surgeons in terms of the ideal locations for harvest. In the present study, we have attempted to present a reasonable alternative to the previously documented harvest sites, including the iliac crest, vertebral body, proximal tibia, and distal femur, using a defined method of determining the presence of hMSCs. Although no surgical procedure can be considered completely "benign," the harvest of BMA from the calcaneus has been reported to have a relatively low risk of associated morbidity (21) . Moreover, calcaneal BMA, used in conjunction with carriers, has demonstrated enhanced success (25) . A previous study identified the presence of osteoblastic progenitor cells in BMA from the human calcaneus (26) . However, definitive proof of the actual presence of multipotent hMSCs in BMAs from the human calcaneus has been lacking. To our knowledge, the present study represents the first isolation, characterization, and in vitro differentiation of hMSCs in BMAs harvested from the human calcaneus. All 10 specimens collected from healthy donors were positive for hMSCs according to the currently accepted standard of identification defined by the ISCT (18) . Because the present study was limited to 2 results (positive or negative for hMSCs), a score of 10 of 10 "positive results" is statistically significant, indicating that BMA from the calcaneus is a reliable source for hMSCs.
In the present study, we showed that hMSCs isolated from the human calcaneus have a high capacity for self-renewal and osteogenic differentiation, suggesting their potential use in bone regeneration. Owing to the limited number of MSCs in unprocessed BMA, to gain the maximum potential, the BMA can be further processed to concentrate the MSCs or the isolated hMSCs can be expanded ex vivo before implantation (7, 27) . Ex vivo expanded MSCs and BMA concentrate can provide additional benefits, because they are both rich sources of growth factors, cytokines, and chemokines (28, 29) . Further studies to evaluate the secretome of the ex vivo-expanded calcaneal hMSCs and the growth factor/cytokine/chemokine profile in BMA concentrate from human calcaneus are needed.
Whether BMA harvested from the human calcaneus is as potent as that from the iliac crest and vertebral body has not yet been determined. Advanced analysis is needed to identify the concentration of hMSCs in each aspirate and then compare that with the previously reported concentrations from other sites. One would expect a lower hMSC concentration from calcaneal BMA, which would, thus, require a greater volume for application. Previous reports have suggested that BMA collected from the iliac crest had a greater mean concentration of osteoblastic progenitor cells compared with the calcaneus (26) . Moreover, it is necessary to compare the osteogenic potential of BMAs from the calcaneus to that of aspirates from other sites.
One limitation of the present study was the relatively homogenous population studied. As a preliminary attempt to identify the presence of hMSCs in BMAs from the human calcaneus, patients with factors known to suppress regeneration were excluded. Future study is warranted to assess those factors as potential predictors of BMA quality.
In conclusion, the aspirates collected from the calcaneus contain a healthy population of cells able to adhere to plastic under standard culture conditions; have enhanced expression of positive cell surface markers such as CD105, CD73, and CD90 and suppressed expression of negative cell surface markers such as CD45 and CD34; and have the ability to differentiate into osteoblasts, adipocytes, and chondrocytes in vitro. Using the guidelines set by the ISCT, we infer that multipotent hMSCs were successfully isolated from BMA collected from the human calcaneus. They maintained the ability to proliferate and differentiate into cells of mesenchymal lineage. The BMA from the calcaneal body offers a reliable and healthy source of multipotent MSCs.
